Currently, around 50 companies claim to manufacture peptide-based therapeutics:::

The inherent advantages of peptide therapeutics, such as small size, low immunogenicity and better cellular uptake, has led to a rise in interest in such interventions. This is anticipated to create significant opportunities for CMOs offering peptide manufacturing services. However, in order to meet the current and future demand, contract manufacturers may need to strengthen their respective capabilities and expand available capacities.
 
To order this 250+ page report, which features 100+ figures and 110+ tables, please visit this link
 
The USD 3.2 billion (by 2030) financial opportunity within the peptide therapeutics contract API manufacturing market has been analyzed across the following segments:
Scale of Operation
  • Clinical
  • Commercial
Type of Peptide Synthesis Method Used
  • Chemical
  • Non-Chemical
  • Type of Peptide Chemical Synthesis Method Used
  • Liquid Phase Peptide Synthesis
  • Solid Phase Peptide Synthesis
  • Hybrid Phase Peptide Synthesis
  • Company Size
  • Small
  • Mid-sized
  • Large / Very Large
Key geographical regions
North America
Europe
  • Asia Pacific
 
The Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

AmbioPharm

Auspep

Bachem

BCN Peptide

Chinese Peptide

CordenPharma

CPC Scientific

Creative Peptides

CSBio

Hybio Pharmaceutical

PEPTIDE INSTITUTE

PolyPeptide Group

Senn Chemicals

Sinopharm Group

 
Table of Contents
 
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. REGULATORY LANDSCAPE
 
5. COMPETITIVE LANDSCAPE
6. COMPANY PROFILES
7. RECENT DEVELOPMENTS
8. CLINICAL TRIAL ANALYSIS
9. REGIONAL CAPABILITY ANALYSIS            
10. DEMAND ANALYSIS
11. CAPACITY ANALYSIS                                            
12. MAKE VERSUS BUY DECISION MAKING FRAMEWORK
13. MARKET SIZING AND OPPORTUNITY ANALYSIS
14. IMPACT OF THE COVID-19 PANDEMIC ON THE PEPTIDE API CONTRACT MANUFACTURING MARKET
15. SWOT ANALYSIS
16. CONCLUSION
17. SURVEY TRANSCRIPT(S)
18. APPENDIX 1: TABULATED DATA
 
19.APPENDIX 2: LIST OF COMPANIES AND ORGANISTIONS
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected] 


You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
781 Posts

Made with by Mamby